Cargando…
Correction to ‘BAP18 coactivates androgen receptor action and promotes prostate cancer progression’
Autores principales: | Sun, Shiying, Zhong, Xinping, Wang, Chunyu, Sun, Hongmiao, Wang, Shengli, Zhou, Tingting, Zou, Renlong, Lin, Lin, Sun, Ning, Sun, Ge, Wu, Yi, Wang, Botao, Song, Xiaoyu, Cao, Liu, Zhao, Yue |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8754662/ https://www.ncbi.nlm.nih.gov/pubmed/34908150 http://dx.doi.org/10.1093/nar/gkab1265 |
Ejemplares similares
-
BAP18 coactivates androgen receptor action and promotes prostate cancer progression
por: Sun, Shiying, et al.
Publicado: (2016) -
An H3K4me3 reader, BAP18 as an adaptor of COMPASS-like core subunits co-activates ERα action and associates with the sensitivity of antiestrogen in breast cancer
por: Sun, Ge, et al.
Publicado: (2020) -
BAP18 is involved in upregulation of CCND1/2 transcription to promote cell growth in oral squamous cell carcinoma
por: Wang, Xue, et al.
Publicado: (2020) -
MDC1 functionally identified as an androgen receptor co-activator participates in suppression of prostate cancer
por: Wang, Chunyu, et al.
Publicado: (2015) -
PRPF6 promotes androgen receptor/androgen receptor-variant 7 actions in castration-resistant prostate cancer cells
por: Liu, Wei, et al.
Publicado: (2021)